413 related articles for article (PubMed ID: 18424711)
1. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II.
Liang B; Workman C; Lee J; Chew C; Dale BM; Colonna L; Flores M; Li N; Schweighoffer E; Greenberg S; Tybulewicz V; Vignali D; Clynes R
J Immunol; 2008 May; 180(9):5916-26. PubMed ID: 18424711
[TBL] [Abstract][Full Text] [Related]
2. FcRγ-chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cells.
Boross P; van Montfoort N; Stapels DA; van der Poel CE; Bertens C; Meeldijk J; Jansen JH; Verbeek JS; Ossendorp F; Wubbolts R; Leusen JH
J Immunol; 2014 Dec; 193(11):5506-14. PubMed ID: 25355925
[TBL] [Abstract][Full Text] [Related]
3. Cross-linking of CD32 induces maturation of human monocyte-derived dendritic cells via NF-kappa B signaling pathway.
Bánki Z; Kacani L; Müllauer B; Wilflingseder D; Obermoser G; Niederegger H; Schennach H; Sprinzl GM; Sepp N; Erdei A; Dierich MP; Stoiber H
J Immunol; 2003 Apr; 170(8):3963-70. PubMed ID: 12682223
[TBL] [Abstract][Full Text] [Related]
4. MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223).
Andreae S; Buisson S; Triebel F
Blood; 2003 Sep; 102(6):2130-7. PubMed ID: 12775570
[TBL] [Abstract][Full Text] [Related]
5. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.
Onishi Y; Fehervari Z; Yamaguchi T; Sakaguchi S
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10113-8. PubMed ID: 18635688
[TBL] [Abstract][Full Text] [Related]
6. Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells.
Bayry J; Triebel F; Kaveri SV; Tough DF
J Immunol; 2007 Apr; 178(7):4184-93. PubMed ID: 17371975
[TBL] [Abstract][Full Text] [Related]
7. Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells.
Furuta K; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19380-5. PubMed ID: 23129633
[TBL] [Abstract][Full Text] [Related]
8. MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells.
Buisson S; Triebel F
Vaccine; 2003 Feb; 21(9-10):862-8. PubMed ID: 12547595
[TBL] [Abstract][Full Text] [Related]
9. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism.
Chattopadhyay G; Shevach EM
J Immunol; 2013 Dec; 191(12):5875-84. PubMed ID: 24218453
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant-active aqueous extracts from Artemisia rupestris L. improve immune responses through TLR4 signaling pathway.
Zhang A; Yang Y; Wang Y; Zhao G; Yang X; Wang D; Wang B
Vaccine; 2017 Feb; 35(7):1037-1045. PubMed ID: 28111143
[TBL] [Abstract][Full Text] [Related]
12. TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells.
Radhakrishnan S; Arneson LN; Upshaw JL; Howe CL; Felts SJ; Colonna M; Leibson PJ; Rodriguez M; Pease LR
J Immunol; 2008 Dec; 181(11):7863-72. PubMed ID: 19017976
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy.
Teramoto K; Ohshio Y; Fujita T; Hanaoka J; Kontani K
J Cancer Res Clin Oncol; 2013 May; 139(5):861-70. PubMed ID: 23411688
[TBL] [Abstract][Full Text] [Related]
14. MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis.
Hemon P; Jean-Louis F; Ramgolam K; Brignone C; Viguier M; Bachelez H; Triebel F; Charron D; Aoudjit F; Al-Daccak R; Michel L
J Immunol; 2011 May; 186(9):5173-83. PubMed ID: 21441454
[TBL] [Abstract][Full Text] [Related]
15. CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins.
Huard B; Prigent P; Tournier M; Bruniquel D; Triebel F
Eur J Immunol; 1995 Sep; 25(9):2718-21. PubMed ID: 7589152
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia.
Shapiro M; Herishanu Y; Katz BZ; Dezorella N; Sun C; Kay S; Polliack A; Avivi I; Wiestner A; Perry C
Haematologica; 2017 May; 102(5):874-882. PubMed ID: 28154084
[TBL] [Abstract][Full Text] [Related]
17. NKG2D Enhances Double-Negative T Cell Regulation of B Cells.
Hu SH; Zhang LH; Gao J; Guo JH; Xun XD; Xiang X; Cheng Q; Li Z; Zhu JY
Front Immunol; 2021; 12():650788. PubMed ID: 34220808
[TBL] [
